Supply Issues Vygon UK Ltd Blood Collection Needles FTR222 and FTR223 (ICN 2940)

• The supply issue with Blood Collection Needles from Vygon UK Ltd is continuing.
• One product is no longer subject to Protect Demand Management and is now suspended and unavailable to order:
  • FTR223 – Blood Collection Needle Non Safety 21G.
• One product remains subject to Protect Demand Management:
  • FTR222 – Blood Collection Needle Non Safety 22G.
• Two products remain affected in total.
• FTR222 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected product. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 25 July 2025.

• The supply issue with Blood Collection Needles from Vygon UK Ltd is continuing.
• We have updated the product listing with additional indirect alternatives.
• Our online catalogue is in the process of being updated to reflect the product listing.
• FTR222 and FTR223 remain subject to Protect Demand Management.
• Two products remain affected in total.
• These products are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 30 June 2025.

Change:

• The supplier Vygon UK Ltd has informed us of a supply issue with its Blood Collection Needle products.
• There are two product codes affected:
  • FTR222 – Blood Collection Needle Non Safety 22G
  • FTR223 – Blood Collection Needle Non Safety 21G.
• The supply issue is due to increased demand and lead times.
• Due to this ongoing supply issue these products are now being threshold managed as they are subject to Protect Demand Management.

Impact:          

• FTR222 and FTR223 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• There are currently no identified alternative products for FTR223 and FTR223 is the alternative for FTR222.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and for a full list of product codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 30 June 2025.

Next Steps:              

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.